查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1468010

關節內粘稠補充療法市場：按產品、來源、應用和最終用途 - 全球預測 2024-2030

Viscosupplementation Market by Product (Five Injection, Single Injection, Three Injection), Source (Animal, Non-animal), Application, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年關節內粘稠補充療法市場規模為28.3億美元，預計2024年將達30.1億美元，2030年將達43.2億美元，複合年成長率為6.19%。

關節內粘稠補充療法是一種將透明質酸注射到關節（例如膝蓋）的醫療程序，以緩解骨關節炎等疾病引起的疼痛。作為一種非手術治療選擇，關節內粘稠補充療法旨在改善關節功能、減輕疼痛，並可能延遲關節重建手術。關節疾病和運動相關損傷的增加、更容易患這些疾病的老年人數量的增加以及對微創手術的日益偏好是市場成長的主要因素。然而，包括類固醇注射和非藥物治療在內的替代治療方案的存在可能會阻礙市場的成長。然而，透明質酸配方和輸送的技術進步以及醫療保健基礎設施的改善預計將為開拓關節內粘稠補充療法市場創造潛在機會。

主要市場統計
基準年[2023] 28.3億美元
預測年份 [2024] 30.1億美元
預測年份 [2030] 43.2億美元
複合年成長率（%） 6.19%

產品採用三次注射方案來減輕骨關節炎患者的疼痛和改善活動能力的情況正在迅速增加。

5 次注射方案是一種關節內粘稠補充療法，由 5 次透明質酸 (HA) 注射組成。此療程通常每週進行一次，連續5週。它主要用於治療膝骨關節炎，旨在恢復關節內滑液的潤滑性和緩衝性能。單次注射方案提供了單次注射的便利，作為關節內粘稠補充療法的替代方法。這些產品由高濃度的透明質酸配製而成，通常含有交聯劑，可提高關節內治療的耐久性和壽命。三次注射方案是一種廣泛採用的關節內粘稠補充療法，涉及一系列三次透明質酸注射。這些通常每週進行一次，旨在補償關節間隙滑液的黏度。這種治療的主要目標是減輕骨關節炎患者的疼痛並增加活動能力。三次注射方案在更廣泛的五次注射療程和單次注射治療方案之間取得了平衡，在治療承諾和症狀緩解持續時間方面提供了中間位置。

對非動物性透明質酸的來源偏好增加，以消除過敏反應的風險

動物源性透明質酸是獲得用於關節內粘稠補充療法的透明質酸的主要資訊。動物源利用富含透明質酸的公雞冠組織或從其他鳥類的組織中提取。非動物源性透明質酸是透過細菌發酵過程產生的。獸疫鏈球菌等基因工程菌株用於生物合成高純度的透明質酸。非動物HA被認為是安全有效的，消除了與禽類蛋白相關的可能引起過敏反應的風險。此外，由於道德考量和生產一致性，非動物性透明質酸越來越受歡迎。

應用實例關節內粘稠補充療法治療膝骨關節炎的先進應用

手腕關節的關節內粘稠補充療法包括將透明質酸直接注射到受影響的關節中。當傳統的非手術治療（例如止痛藥和物理治療）不夠有效時，可以使用這種治療方法。關節內粘稠補充療法手腕關節的主要好處在於減輕疼痛，進而改善功能和生活品質。關節內粘稠補充療法已被證明是治療方法，特別是那些對傳統治療方法沒有反應的患者。髖關節手術較為複雜，由於髖關節位置較深，通常需要超音波或 X 光導引。與長期使用非類固醇消炎劑（NSAID）相比，關節內粘稠補充療法髖骨關節炎的主要優點是其安全性更高。膝骨關節炎最常使用的是關節內粘稠補充療法。由於膝關節是主要的負重關節，因此非常容易磨損。關節內粘稠補充療法程序旨在恢復因膝骨關節炎而損失的滑液的自然特性。

擴大關節內粘稠補充療法在最終整形外科診所/門診手術中心 (ASC) 中的使用

醫院是關節內粘稠補充療法內替代療法是骨關節炎（尤其是膝關節）患者的一種治療選擇。醫院作為採用多學科方法的綜合醫療機構，對於提供這種微創手術至關重要。關節內粘稠補充療法包括將透明質酸注射到關節中以潤滑關節、緩解疼痛並改善活動能力。整形外科診所和門診手術中心 (ASC) 是經常進行關節內粘稠補充療法的特殊最終使用環境。由於這些中心專注於肌肉骨骼健康，因此非常適合提供關節內粘稠補充療法等針對性治療。 ASC 的便利性、效率和普遍較低的成本使其成為尋求門診治療的患者的有吸引力的選擇。

區域洞察

由於骨關節炎盛行率不斷上升、醫療保健成本不斷上升、人們對微創治療的偏好增加以及 FDA 批准的 HA 產品的普及，美洲市場正在不斷發展。先進的醫療保健系統、對骨關節炎治療選擇的認知不斷提高以及支持性法律規範正在推動歐洲關節內粘稠補充療法市場的成長。由於治療方法的可用性和可負擔性的提高以及骨關節炎競爭性治療方法的普及，中東和非洲的關節內粘稠補充療法市場正在不斷成長。由於骨關節炎的高發生率、不斷擴大的醫療基礎設施以及越來越多的先進骨關節炎治療方法，亞太地區對關節內粘稠補充療法的需求很高。此外，提高關節內粘稠補充療法療效的持續研究預計將推動全球對關節內粘稠補充療法市場的需求。

FPNV定位矩陣

FPNV定位矩陣對於評估關節內粘稠補充療法市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對關節關節內粘稠補充療法市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.關節內粘稠補充療法市場的市場規模與預測為何？

2.在關節內粘稠補充療法市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.關節內粘稠補充療法市場的技術趨勢和法規結構是什麼？

4.關節內粘稠補充療法市場主要供應商的市場佔有率為何？

5. 進入關節內粘稠補充療法市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 骨關節炎非手術治療的需求不斷增加
      • 飲食習慣的改變導致文明病的發生率增加
      • 世界老年人口和肥胖症迅速增加
    • 抑制因素
      • 透明質酸治療的副作用和高成本
    • 機會
      • 基於透明質酸的治療方法的開發不斷取得進展
      • 擴大關節內粘稠補充療法在髕骨軟骨病變中的作用
    • 任務
      • 核准嚴格、潤滑鎮痛持續時間短的監理要求
  • 市場區隔分析
    • 產品：三重注射療法的採用激增，以減輕骨關節炎患者的疼痛並增加活動能力
    • 資料來源：越來越偏好非動物性透明質酸，以消除過敏反應的風險
    • 應用：關節內粘稠補充療法治療膝骨關節炎的應用進展
    • 最終用途：擴大關節內粘稠補充療法在整形外科診所/門診手術中心（ASC）的使用
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章關節內粘稠補充療法市場：依產品

  • 5次注射
  • 單次注射
  • 3次注射

第7章關節內粘稠補充療法市場：依來源分類

  • 動物
  • 非動物的

第8章關節內粘稠補充療法市場：依應用分類

  • 手骨關節炎
  • 髖骨關節炎
  • 膝骨關節炎

第9章關節內粘稠補充療法市場：依最終用途分類

  • 醫院
  • 整形外科診所/門診手術中心 (ASC)

第10章北美和南美關節內粘稠補充療法市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太關節關節內粘稠補充療法市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲關節內粘稠補充療法市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • KiOmed Pharma 和 Arsylab 宣佈建立戰略合作夥伴關係，在法國促銷和分銷 KioMedinevsone，這是一種治療難治性膝骨關節炎的新療法
    • Anika 的 Shingal 在 3 期試驗中達到主要終點

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-0315DDADCE1F

[184 Pages Report] The Viscosupplementation Market size was estimated at USD 2.83 billion in 2023 and expected to reach USD 3.01 billion in 2024, at a CAGR 6.19% to reach USD 4.32 billion by 2030.

Viscosupplementation is a medical procedure involving the injection of hyaluronic acid into a joint, such as the knee, to relieve pain caused by conditions such as osteoarthritis. As a non-surgical treatment option, viscosupplementation aims to improve joint function, reduce pain, and possibly delay joint replacement surgery. Increasing incidences of joint disorders and sport-related injuries, a growing elderly population that is more susceptible to such ailments, and the rising preference for minimally invasive procedures significantly contribute to market growth. However, the existence of alternative treatment options, including steroid injections and non-pharmacologic therapies, may impede market growth. Nevertheless, technological advancements in formulating and delivering hyaluronic acid and healthcare infrastructure improvements are expected to create potential opportunities for developing the viscosupplementation market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.83 billion
Estimated Year [2024] USD 3.01 billion
Forecast Year [2030] USD 4.32 billion
CAGR (%) 6.19%

Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis

The five-injection regimen is a viscosupplementation treatment consisting of five hyaluronic acid (HA) injections. This course of therapy is typically administered once per week over five consecutive weeks. Primarily used for the management of knee osteoarthritis, this treatment aims to restore the lubricating and cushioning properties of the synovial fluid in the joint. The Single-Injection Regimen offers an alternative approach to viscosupplementation with the convenience of a one-time injection. This product is formulated with a high concentration of hyaluronic acid and often includes cross-linking agents that enhance the durability and longevity of the treatment within the joint. The Three-Injection Regimen is a widely adopted viscosupplementation treatment that involves a series of three hyaluronic acid injections. These are typically administered one week apart and are designed to supplement the viscous properties of synovial fluid in the joint space. The primary goal of this treatment is to relieve pain and enhance mobility in patients with osteoarthritis. The three-injection regimen strikes a balance between the more extensive five-injection course and the single-injection alternative, offering a middle ground in terms of treatment commitment and duration of symptom relief.

Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks

Animal-based sources have been the primary means of obtaining hyaluronic acid for viscosupplementation. Animal-based sources utilize tissues from rooster combs, which are rich in hyaluronic acid or are extracted from other avian tissues. Non-animal-based hyaluronic acid is produced through bacterial fermentation processes. Genetically modified strains of bacteria, such as Streptococcus zooepidemicus, are used to biosynthesize high-purity HA. Non-animal HA is considered safe and effective, eliminating the risks associated with avian proteins that can cause hypersensitivity reactions. Additionally, non-animal-based HA has been gaining popularity due to ethical considerations and consistency in production.

Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis

Hyaluronic acid is directly injected into the affected joint in the viscosupplementation treatment for hand osteoarthritis. This treatment is used when traditional non-surgical treatments such as pain medications and physical therapy have not provided adequate relief. The main benefit of viscosupplementation for hand osteoarthritis lies in its pain reduction and, hence, improvement in function and quality of life. Viscosupplementation is a proven therapeutic measure to alleviate pain and improve functionality in patients with hip osteoarthritis, particularly those not responding to conventional treatments. The procedure for the hip joint is more complex, often requiring ultrasound or X-ray guidance due to the hip's deep-seated nature. A key advantage of viscosupplementation in hip osteoarthritis is its superior safety profile compared to long-term use of non-steroidal anti-inflammatory drugs (NSAIDs). Knee osteoarthritis is the most common application for viscosupplementation since the knee is a major weight-bearing joint and, therefore, is highly susceptible to wear and tear. The viscosupplementation procedure aims to restore the natural properties of the synovial fluid lost to knee osteoarthritis.

End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)

Hospitals represent a significant end-use sector for viscosupplementation, a therapeutic option for patients suffering from osteoarthritis, particularly in the knee joint. As comprehensive medical facilities with a multidisciplinary approach, hospitals are pivotal in providing this minimally invasive procedure. Viscosupplementation involves the intra-articular injection of hyaluronic acid to lubricate the joint, alleviate pain, and improve mobility. Orthopedic clinics and Ambulatory Surgical Centers (ASCs) are specialized end-use settings where viscosupplementation is frequently administered. These centers are predominantly focused on musculoskeletal health, making them highly adept at providing targeted therapies like viscosupplementation. The convenience, efficiency, and typically lower costs associated with ASCs make them an attractive option for patients seeking outpatient care.

Regional Insights

The market is evolving in the Americas owing to the growing incidence of osteoarthritis, high healthcare expenditure, increasing preference for minimally invasive procedures, and widespread availability of several FDA-approved HA products. Advanced healthcare systems, increased awareness about osteoarthritis treatment options, and supportive regulatory frameworks are encouraging the growth of the viscosupplementation market in Europe. The Middle East and Africa viscosupplementation market is growing with improving availability and affordability of treatment and the prevalence of competitive treatment modalities for osteoarthritis. The Asia Pacific region represents significant demand for viscosupplementation due to high osteoarthritis prevalence, expanding healthcare infrastructure, and increasing accessibility to advanced osteoarthritis treatments. Besides, ongoing research to improve the efficacy of viscosupplementation therapy is anticipated to propel the demand for the viscosupplementation market globally.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Viscosupplementation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Viscosupplementation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Viscosupplementation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Anika Therapeutics, Inc., Avanos Medical, Inc., Bausch Health Companies Inc., Bioventus LLC, Contipro A.S., DePuy Synthes by Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Ferring B.V., Fidia Farmaceutici S.p.A., Gentex Pharma, LLC, LG Chem Ltd., Lifecore Biomedical, LLC, Quimfa S.A., Regen Lab SA, Sanofi S.A., Seikagaku Corporation, Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Viscosupplementation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Five Injection
    • Single Injection
    • Three Injection
  • Source
    • Animal
    • Non-animal
  • Application
    • Hand Osteoarthritis
    • Hip Osteoarthritis
    • Knee Osteoarthritis
  • End-use
    • Hospitals
    • Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Viscosupplementation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Viscosupplementation Market?

3. What are the technology trends and regulatory frameworks in the Viscosupplementation Market?

4. What is the market share of the leading vendors in the Viscosupplementation Market?

5. Which modes and strategic moves are suitable for entering the Viscosupplementation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
      • 5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
      • 5.1.1.3. Surge in Geriatric Population and Obesity Globally
    • 5.1.2. Restraints
      • 5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
      • 5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis
    • 5.2.2. Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks
    • 5.2.3. Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis
    • 5.2.4. End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Viscosupplementation Market, by Product

  • 6.1. Introduction
  • 6.2. Five Injection
  • 6.3. Single Injection
  • 6.4. Three Injection

7. Viscosupplementation Market, by Source

  • 7.1. Introduction
  • 7.2. Animal
  • 7.3. Non-animal

8. Viscosupplementation Market, by Application

  • 8.1. Introduction
  • 8.2. Hand Osteoarthritis
  • 8.3. Hip Osteoarthritis
  • 8.4. Knee Osteoarthritis

9. Viscosupplementation Market, by End-use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

10. Americas Viscosupplementation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Viscosupplementation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Viscosupplementation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis
    • 13.3.2. Anika's Cingal Successfully Achieves Primary Endpoint in Third Phase III Study

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. VISCOSUPPLEMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. VISCOSUPPLEMENTATION MARKET DYNAMICS
  • FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 72. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 80. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 100. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 105. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 108. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 113. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 116. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 121. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 124. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 129. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 132. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 137. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 140. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 148. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 153. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 156. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 169. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 172. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 177. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 180. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 185. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 188. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 203. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 206. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 211. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 214. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 219. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 222. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 227. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 230. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 235. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 238. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 243. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 246. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 254. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 262. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 267. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 270. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 275. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 278. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 286. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 291. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 292. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 293. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 294. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 299. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 302. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 308. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 310. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 318. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 323. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 326. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 331. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 332. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 333. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 334. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 340. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 342. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 347. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 348. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 349. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 350. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 353. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 354. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030